Related Experiment Video

Updated: Dec 22, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

54.1K

Association of liver cirrhosis severity with anemia: does it matter?

Sonal Singh1, Manish Manrai2, Parvathi V S2

  • 1Department of Internal Medicine, Military Hospital Dehradun (Sonal Singh).

Annals of Gastroenterology
|May 9, 2020
PubMed

Insights

Anemia in liver cirrhosis correlates with disease severity. Lower hemoglobin levels indicate more advanced liver disease, suggesting its potential use in initial patient assessment.

Area of Science:

  • Hepatology
  • Hematology
  • Clinical Medicine

Background:

  • Anemia in liver disease is complex and multifactorial.
  • Anemia severity increases with advanced liver cirrhosis.
  • Anemia can predict liver disease severity.

Purpose of the Study:

  • To investigate the relationship between anemia severity and liver disease progression.
  • To assess hemoglobin levels in relation to liver disease severity scores.

Main Methods:

  • Cross-sectional observational study of 181 anemic cirrhotic patients.
  • Patients grouped by Model for End-Stage Liver Disease (MELD) score and Child-Turcotte-Pugh (CTP) classification.
  • Hemoglobin levels analyzed against CTP class and MELD score.

Main Results:

  • Significant correlation found between CTP class and hemoglobin levels (P<0.001).
  • Hemoglobin levels decrease with increasing liver cirrhosis severity (correlation coefficient -0.671).
  • Macrocytosis was significantly associated with higher MELD scores (>12) (P<0.0001).

Conclusions:

  • Hemoglobin levels decrease as liver disease severity increases.
  • Hemoglobin can aid in the initial assessment of liver disease severity.
  • Further prospective trials are needed to confirm hemoglobin's role in assessing severity and predicting mortality.
Abstract

Keywords:
AnemiaChild-Turcotte-Pugh classliver cirrhosismacrocytosismodel for end-stage liver disease score

More Related Videos

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

10.8K
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

22.2K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
120
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
155
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.7K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
294
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
130
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
954